ImpediMed Limited
IPDQF
$0.0375
$0.017587.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.15M | 2.11M | 1.96M | 2.01M | 1.82M |
| Total Other Revenue | -- | -- | -- | -- | -27.00K |
| Total Revenue | 2.15M | 2.11M | 1.96M | 2.01M | 1.82M |
| Cost of Revenue | 330.50K | 323.70K | 233.60K | 240.20K | 224.70K |
| Gross Profit | 1.82M | 1.78M | 1.72M | 1.77M | 1.60M |
| SG&A Expenses | 3.99M | 3.91M | 4.57M | 4.70M | 3.69M |
| Depreciation & Amortization | 754.90K | 739.30K | 719.10K | 739.40K | 358.80K |
| Other Operating Expenses | 689.90K | 675.60K | 205.90K | 211.70K | 998.70K |
| Total Operating Expenses | 5.81M | 5.69M | 5.73M | 5.89M | 5.35M |
| Operating Income | -3.66M | -3.58M | -3.77M | -3.88M | -3.52M |
| Income Before Tax | -3.87M | -3.79M | -3.63M | -3.73M | -3.31M |
| Income Tax Expenses | 4.80K | 4.70K | 3.60K | 3.70K | 4.30K |
| Earnings from Continuing Operations | -3.87M | -3.79M | -3.63M | -3.73M | -3.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.87M | -3.79M | -3.63M | -3.73M | -3.32M |
| EBIT | -3.66M | -3.58M | -3.77M | -3.88M | -3.52M |
| EBITDA | -3.62M | -3.33M | -3.05M | -3.14M | -3.48M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.03B | 2.03B | 2.02T | 2.02T | 2.02B |
| Average Diluted Shares Outstanding | 2.03B | 2.03B | 2.02T | 2.02T | 2.02B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |